MonTa Biosciences ApS
🇩🇰Denmark
Clinical Trials
2
Active:1
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours
Phase 1
Recruiting
- Conditions
- Advanced Solid Tumor
- Interventions
- Drug: MBS8(1V270)
- First Posted Date
- 2021-04-22
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- MonTa Biosciences ApS
- Target Recruit Count
- 69
- Registration Number
- NCT04855435
- Locations
- 🇧🇪
Institut Jules Bordet, Anderlecht, Belgium
🇩🇰University Hospital of Denmark, Department of Oncology, Copenhagen, Denmark
🇩🇰Herlev and Gentofte Hospital, Center for Cancer Research, Herlev, Denmark
News
No news found